Corteva Inc.

ticker: CTVA step: 01 generated: 2026-05-12 source: quick-research

Corteva Inc. (CTVA) — Business Overview

Business Description

Corteva is a pure-play global agriculture company spun off from DowDuPont in 2019, combining the Pioneer seed business (founded 1926) and DuPont Crop Sciences into a single publicly traded entity. With ~$17B in annual revenue, Corteva is one of the three dominant global ag companies alongside Bayer (Monsanto) and Syngenta (ChemChina). In a landmark strategic move, Corteva's board approved a plan to split the company into two independent public companies by H2 2026 / early 2027: "New Corteva" (crop protection) and "SpinCo" (Pioneer seeds) — unlocking value by allowing each business to optimize capital allocation independently. The separation is designed to surface the higher-quality seed business at an appropriate premium multiple.

Revenue Model

Corteva generates revenue through two segments: (1) Seed (~57% of revenue): Pioneer-branded corn, soybean, canola, and wheat seeds sold to farmers globally; pricing power from genetic traits (herbicide tolerance, insect resistance, yield enhancement) that farmers pay premium royalties for; highly seasonal (spring planting season dominates H1); (2) Crop Protection (~43%): fungicides, herbicides, insecticides, and biologicals sold under the Zorvec, Arylex, Isoclast, Enlist, and Pyovum brands — sold through distributors/retailers to farmers. Revenue is highly seasonal (agricultural calendar), with the Seed segment being more profitable and defensible than Crop Protection.

Products & Services

• Seed — Corn: Pioneer P-series and AQUAmax hybrids; Enlist E3 (herbicide tolerance), PowerCore EZHR (insect resistance + herbicide)
• Seed — Soy: Pioneer, Brevant; Enlist E3 (2,4-D choline + glufosinate tolerance); Xtend
• Seed — Other: Canola (Pioneer HiBreed), wheat (hybrid wheat in development), alfalfa, sunflower
• Crop Protection — Herbicides: Enlist herbicide system (2,4-D choline), Rinskor active (rice), Arylex active (cereals)
• Crop Protection — Fungicides: Zorvec (picarbutrazox), Inatreq active
• Crop Protection — Insecticides: Isoclast active (sulfoxaflor)
• Biologicals: Utrisha N (nitrogen fixation), Pyovum (biological insecticide) — target $1B revenue by 2030
• Digital: Granular farm management software (field-level planning and performance tracking)

Customer Base & Go-to-Market

Corteva sells seeds directly to farmers (through Pioneer's own retail network and independent dealers) and crop protection products through distributors and retailers (ag retailers, cooperatives, farm stores). The company serves large row crop farmers (corn/soy belt in U.S., Brazil, Argentina) and international markets (EMEA, Asia-Pacific). Corteva has relationships with virtually every large-scale corn and soybean farmer in North America through the Pioneer brand. Seed pricing is set annually based on trait technology value, with farmers often committed 12–18 months in advance.

Competitive Position

Corteva holds approximately 35% U.S. corn seed market share (Pioneer is the #1 corn seed brand globally) and #2 in soybeans. In crop protection, Corteva is the #3 global player behind Bayer and Syngenta. The moat in seeds is deep: proprietary genetics take years to develop, farmers are risk-averse and stick with proven hybrids, and Corteva's trait licensing relationships (including with BASF and others for stacked traits) create a durable competitive position. The crop protection business is more commoditized and faces intense pricing pressure from Chinese generics.

Key Facts

• Founded: 2019 (spun off from DowDuPont; Pioneer seeds legacy 1926; DuPont Crop Sciences legacy 1802)
• Headquarters: Indianapolis, Indiana
• Employees: ~21,000
• Exchange: NYSE
• Sector / Industry: Materials / Agricultural Chemicals (also considered Agricultural Sciences)
• Market Cap: ~$55–60B
• Planned split: Seeds ("SpinCo") + Crop Protection ("New Corteva") — H2 2026/early 2027

ticker: CTVA step: 04 generated: 2026-05-12 source: quick-research

Corteva Inc. (CTVA) — Financial Snapshot

Income Statement Summary

FY2025: Revenue $17.40B (+3%); Operating EPS $3.34 (+30%); Operating EBITDA $3.85B (+14%). The significant FY2025 improvement reflects royalty economics normalizing, Seed margin expansion (+19% EBITDA), and cost discipline. FY2026 guidance: Operating EPS $3.45–$3.70 (+3–11%)

Cash Flow & Balance Sheet (FY2025)

Key Ratios (approximate, FY2025)

• P/E (operating): ~22–25x | FCF Yield: ~2.5–3.0%
• EV/EBITDA: ~15–17x | Dividend Yield: ~1.5%
• Revenue Growth (FY2025): +3% | Operating EBITDA Margin: ~22%
• Seed EBITDA margin: ~27% (premium vs. Crop Protection ~15%)

Growth Profile

Corteva's FY2023–2024 were cyclically weak: crop protection pricing was pressured by excess channel inventory (post-pandemic destocking), and commodity price normalization reduced farmer income and capital spending. FY2025 marked a recovery: organic Seed sales up 5%, Crop Protection organic up 3%, operating EBITDA up 14%. The long-term growth algorithm is 4–6% organic revenue growth + margin expansion toward 24–25% operating EBITDA. The biologicals platform (targeting $1B revenue by 2030) and hybrid wheat pipeline are the key long-term innovation drivers. The planned split into Seeds + Crop Protection by H2 2026/early 2027 is the single most important structural catalyst.

Forward Estimates

• FY2026: Operating EPS $3.45–$3.70 (management guidance); EBITDA growth ~7%; revenue growth 2–4%
• Post-split (FY2027+): Seeds company expected to trade at premium multiple (comparable to seed technology companies at 25–30x); Crop Protection at lower multiple (15–18x); sum-of-parts analysis suggests significant value unlock vs. current blended multiple
• Dividend: $0.68/share annualized (~$0.17/quarter); ~1.5% yield; modest growth expected